{"id":26737,"date":"2021-02-02T09:00:00","date_gmt":"2021-02-02T09:00:00","guid":{"rendered":"http:\/\/506b50ab00d726dc184011b5d74bd48e"},"modified":"2024-11-03T15:15:48","modified_gmt":"2024-11-03T15:15:48","slug":"majority-of-patients-with-cancer-are-willing-to-be-vaccinated-against-covid-19","status":"publish","type":"post","link":"https:\/\/ogkologos.com\/en\/majority-of-patients-with-cancer-are-willing-to-be-vaccinated-against-covid-19\/","title":{"rendered":"Majority of Patients With Cancer Are Willing To Be Vaccinated Against COVID-19"},"content":{"rendered":"

In order to better prepare the future vaccination campaign among patients treated or monitored for cancer, a group of investigators from France measured the willingness for the anti-SARS-CoV-2 vaccination in this population. They conducted a cross-sectional survey among ambulatory patients in four French cancer centres and found that a majority of patients who are under active cancer care or on surveillance are willing to be vaccinated against COVID-19. The findings are published on 29 January 2021 in the Annals of Oncology<\/em>.<\/p>\n

The authors wrote in the background that patients with cancer have a variable but confirmed higher risk of severe COVID-19. They advocate that patients with cancer should be a target population for vaccination, despite that they were excluded from the first trials.<\/p>\n

The study team conducted the cross-sectional survey with an anonymous paper questionnaire from 11 November 2020 to 12 December 2020. Among the 1244 delivered questionnaires, 999 were returned (80.3%). The responding population included 56.1% of women, and the median age was 67 (range, 18-97).<\/p>\n

Among the respondents, 47% were under active treatment (chemo- or immunotherapy and\/or radiotherapy), 40% were under surveillance and 13% were under hormonal therapy.<\/p>\n

The majority of surveyed patients received a flu vaccine in 2020 (54.3%) or in previous years (52.2%). A very small proportion of respondents reported that had COVID-19 (2.8%).<\/p>\n

Among the respondents, 536 (53.7%) reported their intent to be vaccinated as soon as the vaccine was available, whereas 297 (29.7%) considered they were not ready yet but likely to change their mind. However, 166 patients reported to definitively refuse vaccination (16.6%).<\/p>\n

Among patients in favour of vaccination, the main reasons were fear about their health (76.9%), the desire to protect their relatives (49.9%), the duty for collective responsibility (45.6%) and the wish to return to a normal life (38.7%).<\/p>\n

Among patients who were not sure about vaccination, the arguments that could convince them to be vaccinated were to obtain more information on efficacy (59.4%), on safety (50.3%), on the type of vaccine administered (35.2%) and in only 7.4% collective responsibility or return to a normal life.<\/p>\n

Among patients who did not support vaccination, the main reasons were the lack of confidence in the scientific results (88%), fear of side effects (30%) and believing that COVID-19 is benign in only few respondents (3.6%).<\/p>\n

The predictors for vaccination acceptance in multivariate analysis were history of influenza vaccination, male sex and age older than 69 years.<\/p>\n

Majority of the respondents considered that the oncologists are qualified to advise the patients in terms of vaccination.<\/p>\n

The authors underlined that the studies with stratification according to the type of treatment and the type of vaccine are a priority for the international oncology community.<\/p>\n

Reference<\/h4>\n

Barri\u00e8re J, Gal J, Hoch B, et al.<\/em> Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey<\/a>. Annals of Oncology<\/em>; Published online 29 January 2021. DOI: https:\/\/doi.org\/10.1016\/j.annonc.2021.01.066<\/p>\n

Source<\/a><\/p>","protected":false},"excerpt":{"rendered":"

In order to better prepare the future vaccination campaign among patients treated or monitored for cancer, a group of investigators from France measured the willingness for the anti-SARS-CoV-2 vaccination in this population. They conducted a cross-sectional survey among ambulatory patients in four French cancer centres and found that a majority of patients who are under […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[5137],"tags":[],"class_list":["post-26737","post","type-post","status-publish","format-standard","hentry","category-world-news"],"_links":{"self":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/26737","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/comments?post=26737"}],"version-history":[{"count":1,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/26737\/revisions"}],"predecessor-version":[{"id":43979,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/26737\/revisions\/43979"}],"wp:attachment":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/media?parent=26737"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/categories?post=26737"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/tags?post=26737"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}